Publication

Larson K, Kannaiyan R, Pandey R, Chen Y, Babiker HM, Mahadevan D. 2020. A Comparative Analysis of Tumors and Plasma Circulating Tumor DNA in 145 Advanced Cancer Patients Annotated by 3 Core Cellular Processes. Cancers (Basel). 12. doi:10.3390/cancers12030701.

Recio-Boiles A, Vondrak J, Veeravelli S, Mancuso JJ, Saboda K, Roe DJ, Riaz IB, Scott AJ, Elquza E, McBride A, et al. 2020. Analyzing outcomes of neoadjuvant and adjuvant treatment for borderline-resectable pancreatic adenocarcinoma in the perioperative period at an academic institution. Ann Pancreat Cancer. 3. doi:10.21037/apc.2020.02.01.

Alkhushaym N, Almutairi AR, Althagafi A, Fallatah SB, Oh M, Martin JR, Babiker HM, McBride A, Abraham I. 2020. Exposure to proton pump inhibitors and risk of pancreatic cancer: a meta-analysis. Expert Opin Drug Saf. 19:327–334. doi:10.1080/14740338.2020.1715939.

Kundu A, Shelar S, Ghosh AP, Ballestas M, Kirkman R, Nam H, Brinkley GJ, Karki S, Mobley JA, Bae S, et al. 2020. 14-3-3 proteins protect AMPK-phosphorylated ten-eleven translocation-2 (TET2) from PP2A-mediated dephosphorylation. Journal of Biological Chemistry. 295(6):1754–1766.

Colón-Díaz M, Ortiz-Santana J, Craig ZR. 2020. Data on the activity of DNA methyltransferase in the uteri of CD-1 mice exposed to dibutyl phthalate. Data Brief. 28:105061. doi:10.1016/j.dib.2019.105061.

Kozák L, Szilágyi Z, Tóth L, Pócsi I, Molnár I. 2020 Feb. Functional characterization of the idtF and idtP genes in the Claviceps paspali indole diterpene biosynthetic gene cluster. Folia Microbiol (Praha). doi:10.1007/s12223-020-00777-6.

Fox RS, Ancoli-Israel S, Roesch SC, Merz EL, Mills SD, Wells KJ, Sadler GR, Malcarne VL. 2020. Sleep disturbance and cancer-related fatigue symptom cluster in breast cancer patients undergoing chemotherapy. Support Care Cancer. 28:845–855. doi:10.1007/s00520-019-04834-w.

Jackson R, Maarsingh JD, Herbst-Kralovetz MM, Van Doorslaer K. 2020. 3D Oral and Cervical Tissue Models for Studying Papillomavirus Host-Pathogen Interactions. Curr Protoc Microbiol. 59:e129. doi:10.1002/cpmc.129.

Domcke S, Hill AJ, Daza RM, Cao J, O’Day DR, Pliner HA, Aldinger KA, Pokholok D, Zhang F, Milbank JH, et al. 2020. A human cell atlas of fetal chromatin accessibility. Science. 370. doi:10.1126/science.aba7612.

Eshleman N, Luo X, Capaldi A, Buchan JR. 2020. Alterations of signaling pathways in response to chemical perturbations used to measure mRNA decay rates in yeast. RNA. 26:10–18. doi:10.1261/rna.072892.119.

Chen Y, Navratilova E, Dodick DW, Porreca F. 2020. An Emerging Role for Prolactin in Female-Selective Pain. Trends Neurosci. 43:635–648. doi:10.1016/j.tins.2020.06.003.

Chebet JJ, Thomson CA, Kohler LN, Ehiri JE, Luo J, Cheng T-YD, Pan K, Chlebowski RT, Nassir R, Sealy-Jefferson S, et al. 2020. Association of Diet Quality and Physical Activity on Obesity-Related Cancer Risk and Mortality in Black Women: Results from the Women’s Health Initiative. Cancer Epidemiol Biomarkers Prev. 29:591–598. doi:10.1158/1055-9965.EPI-19-1063.

Kunihiro AG, Luis PB, Frye JB, Chew W, Chow HH, Schneider C, Funk JL. 2020. Bone-Specific Metabolism of Dietary Polyphenols in Resorptive Bone Diseases. Mol Nutr Food Res. 64:e2000072. doi:10.1002/mnfr.202000072.

Blaes A, Vogel RI, Nagler RH, Allen A, Mason S, Teoh D, Talley K, Raymond NC, Wyman JF. 2020. Breast Cancer Screening Practices for High-Risk Women: A Cross-Sectional Survey of Primary Care Providers. J Womens Health (Larchmt). 29:686–692. doi:10.1089/jwh.2018.7463.

Kawaguchi T, Rollins MG, Moinpour M, Morera AA, Ebmeier CC, Old WM, Schwartz JC. 2020. Changes to the TDP-43 and FUS Interactomes Induced by DNA Damage. J Proteome Res. 19:360–370. doi:10.1021/acs.jproteome.9b00575.

Chipollini J, Wright JR, Nwanosike H, Kepler CY, Batai K, Lee BR, Spiess PE, Stewart DB, Lamendella R. 2020. Characterization of urinary microbiome in patients with bladder cancer: Results from a single-institution, feasibility study. Urol Oncol. 38:615–621. doi:10.1016/j.urolonc.2020.04.014.

Segar JM, Pandey R, Farr KJ, Nagle R, LeBeau L, Gonzalez VJ, Chalasani P. 2020. Clinicopathological and Molecular Characteristics of Pleomorphic Invasive Lobular Carcinoma. Int J Breast Cancer. 2020:8816824. doi:10.1155/2020/8816824.

Stahl E, Nott R, Koessel K, Cance W, Marlowe T. 2020. Computational-based discovery of FAK FERM domain chemical probes that inhibit HER2-FAK cancer signaling. Chem Biol Drug Des. 95:584–599. doi:10.1111/cbdd.13671.

Armin JS, Nair U, Giacobbi P, Povis G, Barraza Y, Gordon JS. 2020. Developing a Guided Imagery Telephone-Based Tobacco Cessation Program for a Randomized Controlled Trial. Tob Use Insights. 13:1179173X20949267. doi:10.1177/1179173X20949267.

Marlowe T, Alvarado C, Rivera A, Lenzo F, Nott R, Bondugji D, Montoya J, Hurley A, Kaplan M, Capaldi A, et al. 2020. Development of a High-Throughput Fluorescence Polarization Assay to Detect Inhibitors of the FAK-Paxillin Interaction. SLAS Discov. 25:21–32. doi:10.1177/2472555219874313.

Skiba MB, McElfresh JJ, Howe CL, Crane TE, Kopp LM, Jacobs ET, Thomson CA. 2020. Dietary Interventions for Adult Survivors of Adolescent and Young Adult Cancers: A Systematic Review and Narrative Synthesis. J Adolesc Young Adult Oncol. 9:315–327. doi:10.1089/jayao.2019.0105.

Moinpour M, Barker NK, Guzman LE, Jewett JC, Langlais PR, Schwartz JC. 2020. Discriminating changes in protein structure using tyrosine conjugation. Protein Sci. 29:1784–1793. doi:10.1002/pro.3897.

Vrba L, Oshiro MM, Kim SS, Garland LL, Placencia C, Mahadevan D, Nelson MA, Futscher BW. 2020. DNA methylation biomarkers discovered detect cancer in liquid biopsies from non-small cell lung cancer patients. Epigenetics. 15:419–430. doi:10.1080/15592294.2019.1695333.

Menon U, Szalacha LA, Kue J, Herman PM, Lance P, Bucho-Gonzalez J, Larkey L. 2020. Effects of a Community-to-Clinic Navigation Intervention on Colorectal Cancer Screening Among Underserved People. Ann Behav Med. 54:308–319. doi:10.1093/abm/kaz049.

Trejo MJ, Lishimpi K, Kalima M, Mwaba CK, Banda L, Chuba A, Chama E, Msadabwe SC, Bell ML, Harris RB, et al. 2020. Effects of HIV status on non-metastatic cervical cancer progression among patients in Lusaka, Zambia. Int J Gynecol Cancer. 30:613–618. doi:10.1136/ijgc-2019-000987.